348 related articles for article (PubMed ID: 32534452)
1. From causes of aging to death from COVID-19.
Blagosklonny MV
Aging (Albany NY); 2020 Jun; 12(11):10004-10021. PubMed ID: 32534452
[TBL] [Abstract][Full Text] [Related]
2. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
Front Immunol; 2020; 11():1748. PubMed ID: 32849623
[TBL] [Abstract][Full Text] [Related]
3. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.
Salah HM; Naser JA; Calcaterra G; Bassareo PP; Mehta JL
Am J Cardiol; 2020 Nov; 134():155-157. PubMed ID: 32892991
[No Abstract] [Full Text] [Related]
5. Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung.
Dastan F; Abedini A; Shahabi S; Kiani A; Saffaei A; Zare A
Iran J Allergy Asthma Immunol; 2020 May; 19(S1):10-12. PubMed ID: 32534505
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.
Singh AK; Singh R
Diabetes Res Clin Pract; 2020 Sep; 167():108382. PubMed ID: 32853686
[TBL] [Abstract][Full Text] [Related]
7. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.
Ayaz S; Crea F
Epigenomics; 2020 May; 12(10):811-812. PubMed ID: 32495654
[No Abstract] [Full Text] [Related]
8. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
Guo X; Zhu Y; Hong Y
Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
[No Abstract] [Full Text] [Related]
9. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
[TBL] [Abstract][Full Text] [Related]
10. Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality.
Smetana K; Rosel D; BrÁbek J
In Vivo; 2020; 34(5):3027-3028. PubMed ID: 32871847
[TBL] [Abstract][Full Text] [Related]
11. A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol.
Fragoso-Saavedra S; Iruegas-Nunez DA; Quintero-Villegas A; García-González HB; Nuñez I; Carbajal-Morelos SL; Audelo-Cruz BM; Arias-Martínez S; Caro-Vega Y; Calva JJ; Luqueño-Martínez V; González-Duarte A; Crabtree-Ramírez B; Crispín JC; Sierra-Madero J; Belaunzarán-Zamudio PF; Valdés-Ferrer SI
BMC Infect Dis; 2020 Oct; 20(1):765. PubMed ID: 33066761
[TBL] [Abstract][Full Text] [Related]
12. Can an Old Ally Defeat a New Enemy?
Gurbel PA; Bliden KP; Schrör K
Circulation; 2020 Jul; 142(4):315-317. PubMed ID: 32478567
[No Abstract] [Full Text] [Related]
13. Targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19: Can it be a novel therapeutic strategy?
Kazama I
Drug Discov Ther; 2020 Jul; 14(3):143-144. PubMed ID: 32581194
[TBL] [Abstract][Full Text] [Related]
14. Tackling UK's mortality problem: covid-19 and other causes.
Raleigh VS
BMJ; 2020 Jun; 369():m2295. PubMed ID: 32527731
[No Abstract] [Full Text] [Related]
15. SARS-CoV-2 & Covid-19: Key-Roles of the 'Renin-Angiotensin' System / Vitamin D Impacting Drug and Vaccine Developments.
Cao Z; Wu Y; Faucon E; Sabatier JM
Infect Disord Drug Targets; 2020; 20(3):348-349. PubMed ID: 32370727
[No Abstract] [Full Text] [Related]
16. Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D.
La Vignera S; Cannarella R; Condorelli RA; Torre F; Aversa A; Calogero AE
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331343
[TBL] [Abstract][Full Text] [Related]
17. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
Elife; 2020 Apr; 9():. PubMed ID: 32338605
[TBL] [Abstract][Full Text] [Related]
18. [Theory and practice of aging upon COVID-19 pandemic.].
Golubev AG; Sidorenko AV
Adv Gerontol; 2020; 33(2):397-408. PubMed ID: 32593259
[TBL] [Abstract][Full Text] [Related]
19. Microdose lithium reduces cellular senescence in human astrocytes - a potential pharmacotherapy for COVID-19?
Viel T; Chinta S; Rane A; Chamoli M; Buck H; Andersen J
Aging (Albany NY); 2020 Jun; 12(11):10035-10040. PubMed ID: 32534451
[TBL] [Abstract][Full Text] [Related]
20. Europe's War against COVID-19: A Map of Countries' Disease Vulnerability Using Mortality Indicators.
Horobet A; Simionescu AA; Dumitrescu DG; Belascu L
Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32916973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]